Trade Names: | |
Synonyms: | |
Status: | Approved (2015) |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
ATC: | L04AC10 |
UNII: | DLG4EML025 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Interleukin 17A inhibitor | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Spondylitis, Ankylosing | 3 | D013167 | ClinicalTrials |
Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
Behcet Syndrome | 3 | D001528 | ClinicalTrials |
Uveitis | 3 | D014605 | ClinicalTrials |
Osteoarthritis | 3 | D010003 | ClinicalTrials |
Hidradenitis Suppurativa | 3 | D017497 | ClinicalTrials |
Giant Cell Arteritis | 3 | D013700 | ClinicalTrials |
Lupus Nephritis | 3 | D008181 | ClinicalTrials |
Graves Ophthalmopathy | 3 | D049970 | ClinicalTrials |
Dermatitis, Atopic | 2 | D003876 | ClinicalTrials |
Dry Eye Syndromes | 2 | D015352 | ClinicalTrials |
Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
Diabetes Mellitus, Type 1 | 2 | D003922 | ClinicalTrials |
Pyoderma | 2 | D011711 | ClinicalTrials |
Lupus Erythematosus, Discoid | 2 | D008179 | ClinicalTrials |
Tendinopathy | 2 | D052256 | ClinicalTrials |
Polymyalgia Rheumatica | 2 | D011111 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Necrobiosis Lipoidica | 2 | D009335 | ClinicalTrials |
Alopecia Areata | 2 | D000506 | ClinicalTrials |
Crohn Disease | 2 | D003424 | ClinicalTrials |
Multiple Sclerosis, Relapsing-Remitting | 2 | D020529 | ClinicalTrials |
Pityriasis Rubra Pilaris | 1 | D010916 | ClinicalTrials |
Rosacea | 1 | D012393 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1229022-83-6 |
ChEMBL | CHEMBL1743068 |
FDA SRS | DLG4EML025 |
Guide to Pharmacology | 8078 |